Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report - Takeaways - MDSpire

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report

  • By

  • Jinjin Li

  • Ke Li

  • Shanshan Yu

  • Ya Li

  • Jiang Min

  • Zhen Huang

  • Zhengqiang Wei

  • May 5, 2026

  • 0 min

Share

  • 1

    Dedifferentiated liposarcoma (DDLPS) can trigger severe cytokine release syndrome, complicating surgical management due to paraneoplastic symptoms.

  • 2

    A 56-year-old male with recurrent DDLPS presented with high fever, leukocytosis, severe anemia, and thrombocytopenia, necessitating urgent intervention.

  • 3

    Tocilizumab, an IL-6 receptor antagonist, effectively stabilized the patient's inflammatory state, allowing for successful surgical resection.

  • 4

    Postoperative pathology confirmed DDLPS, and all paraneoplastic symptoms normalized after surgery, although tumor recurrence was later observed.

  • 5

    This case illustrates the potential of targeted anti-cytokine therapy as a bridging treatment for managing severe systemic inflammatory responses in tumors.

Original Source(s)

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report

  • by Jinjin Li, Ke Li, Shanshan Yu, Ya Li, Jiang Min, Zhen Huang, Zhengqiang Wei

  • May 5, 2026

Related Content

Merging evans syndrome with mucopolysaccharidosis type II: a case report

Circulating Immune Complexes and Glucose-6-Phosphate Dehydrogenase Deficiency Predict Recurrent Blackwater Fever in Ugandan Children With Severe Malaria

Prevalence of colorectal cancer and its precursor lesions in symptomatic patients under 55 years of age undergoing total colonoscopy: results of a large retrospective, multicenter, controlled endoscopy study